TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Indegene Limited ( (IN:INDGN) ) has issued an update.
Indegene Limited’s board has approved several key initiatives, including the allotment of shares under the ESOP 2020 Plan and RSU 2020 Plan, and an investment of up to Euro 8.5 million in its wholly-owned subsidiary, Indegene Ireland Limited. Additionally, the board has approved amendments to the Anti-Sexual Harassment Policy and noted grants under various stock option plans. These decisions are likely to strengthen Indegene’s operational capabilities and enhance its market positioning, potentially benefiting stakeholders by driving growth and ensuring compliance with regulatory standards.
More about Indegene Limited
Indegene Limited operates in the healthcare industry, focusing on providing healthcare solutions and services. The company specializes in offering technology-driven solutions to enhance healthcare delivery and improve patient outcomes.
Average Trading Volume: 21,518
Technical Sentiment Signal: Strong Sell
Current Market Cap: 131.2B INR
For detailed information about INDGN stock, go to TipRanks’ Stock Analysis page.

